FATTIZZO, BRUNO
 Distribuzione geografica
Continente #
NA - Nord America 3.854
EU - Europa 2.834
AS - Asia 1.369
SA - Sud America 215
AF - Africa 127
OC - Oceania 94
Continente sconosciuto - Info sul continente non disponibili 2
Totale 8.495
Nazione #
US - Stati Uniti d'America 3.634
IT - Italia 1.371
CN - Cina 409
GB - Regno Unito 288
IN - India 227
FR - Francia 211
DE - Germania 188
JP - Giappone 153
ES - Italia 111
CA - Canada 105
MX - Messico 92
NL - Olanda 87
TH - Thailandia 82
AU - Australia 76
GR - Grecia 76
KR - Corea 64
ID - Indonesia 60
BR - Brasile 58
EG - Egitto 58
CO - Colombia 50
HK - Hong Kong 49
IE - Irlanda 47
CH - Svizzera 42
RU - Federazione Russa 42
UA - Ucraina 42
FI - Finlandia 41
PL - Polonia 40
IR - Iran 37
PE - Perù 37
IL - Israele 34
SG - Singapore 33
TR - Turchia 33
PH - Filippine 32
CZ - Repubblica Ceca 29
CL - Cile 28
AE - Emirati Arabi Uniti 26
AT - Austria 26
AR - Argentina 25
BE - Belgio 25
SE - Svezia 24
ZA - Sudafrica 22
RO - Romania 21
VN - Vietnam 21
PT - Portogallo 20
DK - Danimarca 19
SA - Arabia Saudita 19
NZ - Nuova Zelanda 18
MY - Malesia 17
HR - Croazia 14
HU - Ungheria 13
PK - Pakistan 13
TW - Taiwan 12
NO - Norvegia 11
JO - Giordania 9
LB - Libano 9
TN - Tunisia 9
DZ - Algeria 8
EC - Ecuador 8
IQ - Iraq 8
MA - Marocco 8
SK - Slovacchia (Repubblica Slovacca) 8
LK - Sri Lanka 7
PR - Porto Rico 7
RS - Serbia 7
TZ - Tanzania 7
MK - Macedonia 6
VE - Venezuela 6
UG - Uganda 5
AL - Albania 4
BG - Bulgaria 4
CU - Cuba 4
MD - Moldavia 4
NI - Nicaragua 4
SI - Slovenia 4
BO - Bolivia 3
CR - Costa Rica 3
EU - Europa 3
LT - Lituania 3
PS - Palestinian Territory 3
BA - Bosnia-Erzegovina 2
CY - Cipro 2
GD - Grenada 2
GH - Ghana 2
MO - Macao, regione amministrativa speciale della Cina 2
NG - Nigeria 2
OM - Oman 2
QA - Qatar 2
AD - Andorra 1
BJ - Benin 1
BY - Bielorussia 1
CM - Camerun 1
DO - Repubblica Dominicana 1
IS - Islanda 1
KE - Kenya 1
KZ - Kazakistan 1
LA - Repubblica Popolare Democratica del Laos 1
LV - Lettonia 1
LY - Libia 1
MU - Mauritius 1
NP - Nepal 1
Totale 8.492
Città #
Milan 367
Ashburn 315
Fairfield 260
Santa Cruz 212
Woodbridge 168
Houston 165
Beijing 153
Seattle 145
Wilmington 88
Cambridge 87
Ann Arbor 85
Rome 81
Buffalo 80
San Diego 47
Redmond 45
Dublin 42
Southend 42
Bangkok 40
Los Angeles 40
New York 40
Athens 39
Chennai 38
Chicago 38
Duncan 38
Helsinki 38
Tokyo 38
Boardman 37
Bogotá 33
Turin 33
Amsterdam 32
Florence 32
Shanghai 32
Bengaluru 31
Lima 30
Paris 30
London 28
Naples 28
Las Vegas 27
Tianjin 25
Des Moines 24
Madrid 24
Melbourne 24
Bologna 23
Cairo 21
Sydney 20
Central 19
Frankfurt am Main 18
Dallas 17
Hangzhou 17
Council Bluffs 16
Manchester 16
Milpitas 16
Nanjing 16
Padova 16
San Francisco 16
Warsaw 16
Delhi 15
Hyderabad 15
Pontedera 15
Toronto 15
Atlanta 14
Bari 14
Columbia 14
Genoa 14
Lake Forest 14
Liverpool 14
Mexico City 14
Monza 14
São Paulo 14
Verona 14
Lviv 13
Palermo 13
Vienna 13
Barcelona 12
Berlin 12
Ottawa 12
Santiago 12
Guangzhou 11
Gurgaon 11
Ho Chi Minh City 11
Hong Kong 11
New Delhi 11
Seoul 11
Stockholm 11
Trieste 11
Brussels 10
Budapest 10
Chengdu 10
Clearwater 10
Columbus 10
Kuala Lumpur 10
Mumbai 10
Portland 10
Provo 10
San Juan 10
Singapore 10
Tappahannock 10
Tehran 10
Westbury 10
Auckland 9
Totale 3.972
Nome #
How I treat warm autoimmune hemolytic anemia, file dfa8b9a9-e13d-748b-e053-3a05fe0a3a96 648
A case of severe aplastic anaemia after SARS-CoV-2 vaccination, file dfa8b9a9-ba6e-748b-e053-3a05fe0a3a96 498
Clinical heterogeneity and predictors of outcome in primary autoimmune hemolytic anemia : a GIMEMA study of 308 Patients, file dfa8b9a3-05f7-748b-e053-3a05fe0a3a96 464
Anemia emolitica autoimmune dall’approccio classico ai nuovi farmaci, file dfa8b9a3-05fc-748b-e053-3a05fe0a3a96 461
Predictors of refractoriness to therapy and healthcare resource utilization in 378 patients with primary autoimmune hemolytic anemia from eight Italian reference centers, file dfa8b9a3-41a4-748b-e053-3a05fe0a3a96 425
Short course of bortezomib in anemic patients with relapsed cold agglutinin disease : a phase 2 prospective GIMEMA study, file dfa8b9a3-2887-748b-e053-3a05fe0a3a96 272
Efficacy of recombinant erythropoietin in autoimmune haemolytic anaemia: a multicentre international study, file dfa8b9a3-c028-748b-e053-3a05fe0a3a96 247
Management of refractory autoimmune hemolytic anemia after allogeneic hematopoietic stem cell transplantation : current perspectives, file dfa8b9a2-fb68-748b-e053-3a05fe0a3a96 235
Concomitant Occurrence of Blastic Plasmacytoid Dendritic Cell Neoplasm and Acute Myeloid Leukaemia after Lenalidomide Treatment for del(5q) Myelodysplastic Syndrome, file dfa8b99b-34d4-748b-e053-3a05fe0a3a96 219
Iron mobilization in a real life cohort of aplastic anemia patients treated with eltrombopag, file dfa8b9a3-6be5-748b-e053-3a05fe0a3a96 216
Circulating extracellular vesicles and cytokines in congenital and acquired hemolytic anemias, file dfa8b9a5-e3e9-748b-e053-3a05fe0a3a96 206
Low-dose rituximab in autoimmune hemolytic anemia : 10 years after, file dfa8b9a3-0936-748b-e053-3a05fe0a3a96 184
Innovative Treatments for Rare Anemias, file dfa8b9a7-ccf3-748b-e053-3a05fe0a3a96 180
Seasonal variation in the incidence of cold agglutinin disease in Norway, Denmark, and Italy, file dfa8b9a9-d4b0-748b-e053-3a05fe0a3a96 178
Predictors of refractoriness to therapy and healthcare resource utilization in 378 patients with primary autoimmune hemolytic anemia from eight Italian reference centers, file dfa8b9a3-6284-748b-e053-3a05fe0a3a96 175
Paroxysmal Nocturnal Hemoglobinuria (Pnh) : Brain Mri Ischemic Lesions in Neurologically Asymtomatic Patients, file dfa8b99a-5fa1-748b-e053-3a05fe0a3a96 145
Autoimmune Cytopenias in Chronic Lymphocytic Leukemia: Focus on Molecular Aspects, file dfa8b9a3-1df1-748b-e053-3a05fe0a3a96 137
Clinical and Morphologic Predictors of Outcome in a Multicenter Cohort of ITP Patients Treated with Trombopoietin Analogues, file dfa8b9a3-5036-748b-e053-3a05fe0a3a96 135
The Changing Landscape of Autoimmune Hemolytic Anemia, file dfa8b9a3-1c4a-748b-e053-3a05fe0a3a96 134
Multifactorial neutropenia in a patient with acute promyelocytic leukemia and associated large granular lymphocyte expansion: A case report, file dfa8b998-8781-748b-e053-3a05fe0a3a96 128
Mesenchymal Stem Cells in Myeloid Malignancies: A Focus on Immune Escaping and Therapeutic Implications, file dfa8b99a-6817-748b-e053-3a05fe0a3a96 127
Off-Label Use of Thrombopoietin Receptor Agonists: Case Series and Review of the Literature, file dfa8b9a9-b845-748b-e053-3a05fe0a3a96 123
Hypoplastic myelodysplastic syndromes: Just an overlap syndrome?, file dfa8b9a9-8a6c-748b-e053-3a05fe0a3a96 121
Small Paroxysmal Nocturnal Hemoglobinuria Clones in Autoimmune Hemolytic Anemia: Clinical Implications and Different Cytokine Patterns in Positive and Negative Patients, file dfa8b9a3-41aa-748b-e053-3a05fe0a3a96 120
Bone marrow characteristics predict outcome in a multicenter cohort of primary immune thrombocytopenia patients treated with thrombopoietin analogs, file dfa8b9a3-41a8-748b-e053-3a05fe0a3a96 113
SARS-CoV-2 vaccination induces breakthrough hemolysis in paroxysmal nocturnal hemoglobinuria on complement inhibitor, file dfa8b9a9-7bc2-748b-e053-3a05fe0a3a96 112
Efficacy and safety of cyclosporine A treatment in autoimmune cytopenias: the experience of two Italian reference centers, file 0add49ab-e43c-4ab0-9099-c815945f788b 105
Prognostic and Predictive Impact of Small PNH Clones in a Large Cohort of Patients with Myelodysplastic Syndromes and Aplastic Anemia: A Single-Center Experience, file dfa8b9a3-364b-748b-e053-3a05fe0a3a96 103
Clinical Applications of Hemolytic Markers in the Differential Diagnosis and Management of Hemolytic Anemia, file dfa8b9a3-41ac-748b-e053-3a05fe0a3a96 98
Impact of Bone Marrow Fibrosis and Early Response on Outcome after Azacitidine Therapy in 94 Patients with Myelodisplastic Syndromes, Chronic Myelomonocytic Leukemia and Acute Myeloid Leukemia, file dfa8b9a3-3cb9-748b-e053-3a05fe0a3a96 97
Large Granular Lymphocyte Expansion in Myeloid Diseases and Bone Marrow Failure Syndromes : Whoever Seeks Finds, file dfa8b9a9-b8bd-748b-e053-3a05fe0a3a96 97
Severe presentation of congenital hemolytic anemias in the neonatal age : diagnostic and therapeutic issues, file dfa8b9a8-08ab-748b-e053-3a05fe0a3a96 95
Predictors of atrial fibrillation in ibrutinib-treated CLL patients : a prospective study, file dfa8b9a3-0445-748b-e053-3a05fe0a3a96 92
Switching to an alternative recombinant erythropoietin agent in patients with myelodysplastic syndromes : a second honeymoon?, file dfa8b9a9-e392-748b-e053-3a05fe0a3a96 92
The Physiopathology of T- Cell Acute Lymphoblastic Leukemia: Focus on Molecular Aspects, file dfa8b9a3-41b0-748b-e053-3a05fe0a3a96 90
Immune Phenomena in Myeloid Neoplasms : An “Egg or Chicken” Question, file dfa8b9a9-8a74-748b-e053-3a05fe0a3a96 87
Recent insights into the role of the microbiome in malignant and benign hematologic diseases, file dfa8b9a9-9e70-748b-e053-3a05fe0a3a96 85
Ensuring continuity of care of hematologic patients during COVID-19 pandemic in a tertiary hospital in Lombardy (Italy), file dfa8b9a2-c97f-748b-e053-3a05fe0a3a96 80
Evans syndrome in adults : an observational multicenter study, file dfa8b9a9-97c5-748b-e053-3a05fe0a3a96 80
Clinical and morphological predictors of outcome in older aplastic anemia patients treated with eltrombopag, file dfa8b9a3-419f-748b-e053-3a05fe0a3a96 77
Are Patients With Autoimmune Cytopenias at Higher Risk of COVID-19 Pneumonia? The Experience of a Reference Center in Northern Italy and Review of the Literature, file dfa8b9a9-9ca6-748b-e053-3a05fe0a3a96 76
Complement Mediated Hemolytic Anemias in the COVID-19 Era : Case Series and Review of the Literature, file dfa8b9a9-b839-748b-e053-3a05fe0a3a96 76
Mesenchymal Stem Cells in Aplastic Anemia and Myelodysplastic Syndromes: The "Seed and Soil" Crosstalk, file dfa8b9a3-26cc-748b-e053-3a05fe0a3a96 67
Clinical and prognostic significance of small paroxysmal nocturnal hemoglobinuria clones in myelodysplastic syndrome and aplastic anemia, file dfa8b9a9-9cb1-748b-e053-3a05fe0a3a96 63
Bortezomib in autoimmune hemolytic anemia and beyond, file dfa8b9a9-7d85-748b-e053-3a05fe0a3a96 61
Infectious complications in autoimmune hemolytic anemia, file dfa8b9a9-cde0-748b-e053-3a05fe0a3a96 61
Co-Occurrence of Myeloid and Lymphoid Neoplasms: Clinical Characterization and Impact on Outcome. A Single-Center Cohort Study, file dfa8b9a9-3f22-748b-e053-3a05fe0a3a96 60
The Immunomodulatory Effect and Clinical Efficacy of Daratumumab in a Patient With Cold Agglutinin Disease, file dfa8b9a9-b8ac-748b-e053-3a05fe0a3a96 60
A Review on Chronic Neutropenia of the Adult: Emerging Clinical Dilemmas, file dfa8b9a3-412e-748b-e053-3a05fe0a3a96 58
Paroxysmal Nocturnal Hemoglobinuria in the Context of a Myeloproliferative Neoplasm: A Case Report and Review of the Literature, file dfa8b9a9-9652-748b-e053-3a05fe0a3a96 58
Second-line administration of thrombopoietin receptor agonists in immune thrombocytopenia: Italian Delphi-based consensus recommendations, file dfa8b9a9-b20a-748b-e053-3a05fe0a3a96 56
Prevalence of small PNH clones and theirprognostic significance in patients tested forunusual indications: a single center experience, file dfa8b9a3-975e-748b-e053-3a05fe0a3a96 55
Low-Risk Myelodysplastic Syndrome Revisited: Morphological, Autoimmune, and Molecular Features as Predictors of Outcome in a Single Center Experience, file 432b9ccc-7eeb-4ba7-a615-c6ffcfea2f03 50
Autoimmune Hemolytic Anemia as a Complication of Congenital Anemias. A Case Series and Review of the Literature, file dfa8b9a7-c961-748b-e053-3a05fe0a3a96 49
Confounding factors in the diagnosis and clinical course of rare congenital hemolytic anemias, file dfa8b9a9-97b7-748b-e053-3a05fe0a3a96 47
Secondary hemophagocytic lymphohistiocytosis and autoimmune cytopenias: Case description and review of the literature, file dfa8b9a9-82f1-748b-e053-3a05fe0a3a96 45
Autoimmune complications in hematologic neoplasms, file dfa8b9a9-b6fb-748b-e053-3a05fe0a3a96 43
Evidence based use of erytrhopoietin in patients with Autoimmune Hemolytic Anemia : a multicenter international study, file dfa8b9a3-5baa-748b-e053-3a05fe0a3a96 39
Difficult cases of autoimmune hemolytic anemia: A challenge for the internal medicine specialist, file dfa8b9a9-b4c1-748b-e053-3a05fe0a3a96 39
Difficult cases of paroxysmal nocturnal hemoglobinuria: Diagnosis and therapeutic novelties, file dfa8b9a9-9ae6-748b-e053-3a05fe0a3a96 36
A Review on Chronic Neutropenia of the Adult: Emerging Clinical Dilemmas, file dfa8b9a3-3f88-748b-e053-3a05fe0a3a96 35
New insights in autoimmune hemolytic anemia : From pathogenesis to therapy stage 1, file dfa8b9a9-b269-748b-e053-3a05fe0a3a96 35
Inhibition of C3 with APL-2 ControlsHaemolysis and Increases Haemoglobin Levelsin Subjects with Autoimmune HaemolyticAnaemia (AIHA), file dfa8b9a3-bcac-748b-e053-3a05fe0a3a96 34
Inhibition of C3 with APL-2 controls haemolysis and increases haemoglobin levels in subjects with Autoimmune Haemolytic Anaemia (AIHA), file dfa8b9a3-5ba6-748b-e053-3a05fe0a3a96 17
Impact of intravascular hemolysis and multitreatment on thrombosis occurrence in autoimmune hemolytic anemia, file dfa8b9a2-fa99-748b-e053-3a05fe0a3a96 16
Short Course of Bortezomib in Anemic Patients with Refractory or Relapsed Cold Agglutinin Disease. a Phase II Prospective Study By the Gimema Group, file dfa8b9a3-5035-748b-e053-3a05fe0a3a96 15
Editorial: Immunologic Mechanisms of Myeloid Neoplasms, file c796a575-d465-49a8-9f0d-495ddce877f1 14
Prevalence and clinical significance of small PNH clones in patiens with primary autoimmune hemolytic anemia, file dfa8b9a3-8282-748b-e053-3a05fe0a3a96 12
Iron mobilization in a real life cohort of aplastic anemia patients treated with eltrombopag, file dfa8b9a2-fb5d-748b-e053-3a05fe0a3a96 9
Reduced 25-OH vitamin D in patients with autoimmune cytopenias, clinical correlations and literature review, file dfa8b995-61e4-748b-e053-3a05fe0a3a96 8
Clinical significance of PNH clones in 3085 patients with cytopenia: a large single-center experience, file dfa8b9a2-fa8c-748b-e053-3a05fe0a3a96 8
Infectious and thrombotic complications and their prognostic impact in patients with concomitant myeloid and lymphoid neoplasms : a single-center cohort study, file 15a622d3-245b-417f-a4f2-7c39ba9f8e94 6
Lessons from very severe, refractory, and fatal primary autoimmune hemolytic anemias, file dfa8b992-d253-748b-e053-3a05fe0a3a96 6
Prognostic impact of bone marrow fibrosis and dyserythropoiesis in autoimmune hemolytic anemia, file dfa8b99a-5c08-748b-e053-3a05fe0a3a96 6
Autoimmune hemolytic anemia, autoimmune neutropenia and aplastic anemia in the elderly, file dfa8b9a3-1de7-748b-e053-3a05fe0a3a96 6
null, file dfa8b9a3-557d-748b-e053-3a05fe0a3a96 6
Evidence based use of erytrhopoietin in patients with Autoimmune Hemolytic Anemia : a multicenter international study, file dfa8b9a3-956e-748b-e053-3a05fe0a3a96 6
Clinical and morphologic predictors of outcome in aplastic anemia patients treated with eltrombopag, file dfa8b9a3-ac3c-748b-e053-3a05fe0a3a96 6
Low-dose rituximab in adult patients with idiopathic autoimmune hemolytic anemia : clinical efficacy and biologic studies, file dfa8b990-5e8d-748b-e053-3a05fe0a3a96 5
Evidence based use of erytrhopoietin in patients with autoimmune hemolytic anemia: a multicenter international study, file dfa8b9a3-3810-748b-e053-3a05fe0a3a96 5
Inhibition of C3 with APL-2 controls haemolysis and increases haemoglobin levels in subjects with Autoimmune Haemolytic Anaemia (AIHA), file dfa8b9a3-bc90-748b-e053-3a05fe0a3a96 5
Sustained response to low-dose rituximab in idiopathic autoimmune hemolytic anemia, file dfa8b991-05b3-748b-e053-3a05fe0a3a96 4
Is chronic neutropenia always a benign disease? Evidences from a 5-year prospective study, file dfa8b995-901f-748b-e053-3a05fe0a3a96 4
Paroxysmal nocturnal hemoglobinuria with spontaneous clinical remission, file dfa8b999-1c90-748b-e053-3a05fe0a3a96 4
Paroxysmal nocturnal hemoglobinuria with spontaneous clinical remission, file dfa8b999-a802-748b-e053-3a05fe0a3a96 4
Eltrombopag in Immune Thrombocytopenia, Aplastic Anemia, and Myelodysplastic Syndrome : From Megakaryopoiesis to Immunomodulation, file dfa8b9a2-fb66-748b-e053-3a05fe0a3a96 4
Eltrombopag in a real world cohort of aplasticanemia patients: large retrospective analysis of two UK centers, file dfa8b9a3-1f49-748b-e053-3a05fe0a3a96 4
Autoimmune hemolytic anemia - progress in emerging treatment options, file dfa8b9a3-34c6-748b-e053-3a05fe0a3a96 4
Clinical course and management of adult-onset immune-mediated cytopenia associated with Kabuki syndrome, file dfa8b9a3-3ff6-748b-e053-3a05fe0a3a96 4
Danazol Treatment for Thrombocytopenia in Myelodysplastic Syndromes: Can an "Old-fashioned" Drug be Effective?, file c8b53906-583e-472b-8f24-58adcb08b448 3
Prognostic impact of bone marrow fibrosis and dyserythropoiesis in autoimmune hemolytic anemia, file dfa8b99b-9364-748b-e053-3a05fe0a3a96 3
Prognostic and predictive impact of small PNH clones in a large cohort of patients with myelodysplastic syndrome and aplastic anemia: a single-center experience, file dfa8b9a3-322f-748b-e053-3a05fe0a3a96 3
Reply to “COVID-19 in persons with haematological cancers”: a focus on myeloid neoplasms and risk factors for mortality, file dfa8b9a3-419b-748b-e053-3a05fe0a3a96 3
Cold agglutinin disease revisited: a multinational, observational study of 232 patients, file dfa8b9a3-41b4-748b-e053-3a05fe0a3a96 3
Prevalence of PNH clones and their clinical and prognostic significance in 3085 patients with cytopenia: a twenty-year single center experience, file dfa8b9a3-5aca-748b-e053-3a05fe0a3a96 3
Increased prevalence of autoimmune phenomena in myelofibrosis : relationship with clinical and morphological characteristics, and with immunoregulatory cytokine patterns, file dfa8b991-0982-748b-e053-3a05fe0a3a96 2
Biological and molecular characterization of a rare case of cutaneous Richter syndrome, file dfa8b995-f61c-748b-e053-3a05fe0a3a96 2
Idelalisib rapidly improves platelet function tests in patients with chronic lymphocytic leukaemia, file dfa8b99a-912d-748b-e053-3a05fe0a3a96 2
Prevalence and clinical significance of small PNH clones in patiens with primary autoimmune hemolytic anemia, file dfa8b9a2-fa93-748b-e053-3a05fe0a3a96 2
Autoimmune hemolytic anemia in adults: primary risk factors and diagnostic procedures, file dfa8b9a2-fb69-748b-e053-3a05fe0a3a96 2
Totale 8.700
Categoria #
all - tutte 19.702
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 19.702


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/201971 0 0 0 0 0 0 0 0 0 12 25 34
2019/2020165 16 9 16 20 23 15 9 8 21 13 8 7
2020/20211.469 10 68 295 250 104 148 90 94 95 106 83 126
2021/20222.180 68 95 72 135 144 81 120 198 295 185 509 278
2022/20232.629 132 172 509 373 217 242 177 151 166 148 214 128
2023/20242.139 151 120 221 204 357 192 287 297 223 87 0 0
Totale 8.763